China’s Internet Hospitals And New Commercial Models For Pharma
Firms In Japan Ascend Digital Adoption Curve
Pharma is leveraging new commercial models in China as part of strategies to offset centralized procurements-induced market share losses and also for new launches, the co- founder of Indegene, a healthtech solutions provider, tells Scrip. He also shares insights on how companies in Japan are shifting digital gears amid COVID-19.
You may also be interested in...
China's latest round of reimbursement decisions show multinationals including AstraZeneca, BMS and Roche won’t be receiving national coverage for their latest immuno-oncology drugs any time soon.
In its most recent regulatory reforms, China is proposing to allow online sales of prescription drugs, a major step forward that could boost struggling retail pharmacies and further propel medicine e-commerce.
Pharma’s digital spend is expected to spurt in the coming years and firms are deploying a range of initiatives to deliver personalized content to physicians via preferred channels. KOL webinars feature among the top three approaches for marketers across the Americas, Europe and Asia, a new survey shows.